Germ-Line and Somatic Presentations of the EGFR T790M Mutation in Lung Cancer

Por Prudkin, Ludmila, Tang, Ximing, Wistuba, Ignacio I.
Publicado no J Thorac Oncol (2009)

Epithelial-to-Mesenchymal Transition in the Development and Progression of Adenocarcinoma and Squamous Cell Carcinoma of the Lung

Por Prudkin, Ludmila, Liu, Diane, Ozburn, Natalie C., Sun, Menghong, Behrens, Carmen, Tang, Ximing, Brown, Kathlynn C., Bekele, B. Nebiyou, Moran, Cesar, Wistuba, Ignacio I.
Publicado em 2009

miR-93, miR-98 and miR-197 regulate expression of tumor suppressor gene FUS1

Por Du, Liqin, Schageman, Jeoffrey J., Subauste, Maria C., Saber, Barbara, Hammond, Scott M., Prudkin, Ludmila, Wistuba, Ignacio I., Ji, Lin, Roth, Jack A., Minna, John D., Pertsemlidis, Alexander
Publicado em 2009

Loss and Reduction of Fus1 Protein Expression is a Frequent Phenomenon in the Pathogenesis of Lung Cancer

Por Prudkin, Ludmila, Behrens, Carmen, Liu, Diane D., Zhou, Xian, Ozburn, Natalie C., Bekele, B. Nebiyou, Minna, John D., Moran, Cesar, Roth, Jack A., Ji, Lin, Wistuba, Ignacio I.
Publicado em 2008

Proteomics-Based Identification of Proteins Secreted in Apical Surface Fluid of Squamous Metaplastic Human Tracheobronchial Epithelial Cells Cultured by Three-Dimensional Organotyp...

Por Kim, Seung-Wook, Cheon, Kyounga, Kim, Chang-Hoon, Yoon, Joo-Heon, Hawke, David H., Kobayashi, Ryuji, Prudkin, Ludmila, Wistuba, Ignacio I., Lotan, Reuben, Hong, Waun Ki, Koo, Ja Seok
Publicado em 2007

Immunohistochemical Expression of Estrogen and Progesterone Receptors Identifies a Subset of NSCLCs and Correlates with EGFR Mutation

Por Raso, Maria G., Behrens, Carmen, Herynk, Matthew H., Liu, Suyu, Prudkin, Ludmila, Ozburn, Natalie C., Woods, Denise M., Tang, Ximing, Mehran, Reza J., Moran, Cesar, Lee, J. Jack, Wistuba, Ignacio I.
Publicado em 2009

A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-ras

Por Yang, Yanan, Wislez, Marie, Fujimoto, Nobukazu, Prudkin, Ludmila, Izzo, Julie G., Uno, Futoshi, Ji, Lin, Hanna, Amy E., Langley, Robert R., Liu, Diane, Johnson, Faye M., Wistuba, Ignacio, Kurie, Jonathan M.
Publicado em 2008

EGFR and K-Ras Mutations and Resistance of Lung Cancer to IGF-1R Tyrosine Kinase Inhibitors

Por Kim, Woo-Young, Prudkin, Ludmila, Feng, Lei, Kim, Edward S., Hennessy, Bryan, Lee, Ju-Seog, Lee, J. Jack, Glisson, Bonnie, Lippman, Scott M., Wistuba, Ignacio I., Hong, Waun Ki, Lee, Ho-Young
Publicado em 2012

Clinical benefit of lapatinib-based therapy in patients with HER2-positive breast tumors co-expressing the truncated p95HER2 receptor

Por Scaltriti, Maurizio, Chandarlapaty, Sarat, Prudkin, Ludmila, Aura, Claudia, Jimenez, José, Angelini, Pier Davide, Sánchez, Gertrudis, Guzman, Marta, Parra, Josep Lluis, Ellis, Catherine, Gagnon, Robert, Koehler, Maria, Gomez, Henry, Geyer, Charles, Cameron, David, Arribas, Joaquin, Rosen, Neal, Baselga, José
Publicado em 2010

Prognostic Significance of Combinations of RNA-Dependent Protein Kinase and EphA2 Biomarkers for NSCLC

Por Guo, Chengcheng, Shao, Ruping, Correa, Arlene M, Behrens, Carmen, Johnson, Faye M., Raso, Maria G., Prudkin, Ludmila, Solis, Luisa M., Nunez, Maria I., Fang, Bingliang, Roth, Jack A., Wistuba, Ignacio I., Swisher, Stephen G., Lin, Tongyu, Pataer, Apar
Publicado em 2013

Elevated Epithelial Insulin-like Growth Factor Expression Is a Risk Factor for Lung Cancer Development

Por Kim, Woo-Young, Jin, Quanri, Oh, Seung-Hyun, Kim, Edward S., Yang, Youn Joo, Lee, Dong Hoon, Feng, Lei, Behrens, Carmen, Prudkin, Ludmila, Miller, York E., Lee, J. Jack, Lippman, Scott M., Hong, Waun Ki, Wistuba, Ignacio I., Lee, Ho-Young
Publicado em 2009

Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2(+) breast cancer patients

Por Scaltriti, Maurizio, Eichhorn, Pieter J., Cortés, Javier, Prudkin, Ludmila, Aura, Claudia, Jiménez, José, Chandarlapaty, Sarat, Serra, Violeta, Prat, Aleix, Ibrahim, Yasir H., Guzmán, Marta, Gili, Magui, Rodríguez, Olga, Rodríguez, Sonia, Pérez, José, Green, Simon R., Mai, Sabine, Rosen, Neal, Hudis, Clifford, Baselga, José
Publicado em 2011

RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer

Por Serra, Violeta, Eichhorn, Pieter J.A., García-García, Celina, Ibrahim, Yasir H., Prudkin, Ludmila, Sánchez, Gertrudis, Rodríguez, Olga, Antón, Pilar, Parra, Josep-Lluís, Marlow, Sara, Scaltriti, Maurizio, Pérez-Garcia, José, Prat, Aleix, Arribas, Joaquín, Hahn, William C., Kim, So Young, Baselga, José
Publicado em 2013

RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer

Por Serra, Violeta, Eichhorn, Pieter J.A., García-García, Celina, Ibrahim, Yasir H., Prudkin, Ludmila, Sánchez, Gertrudis, Rodríguez, Olga, Antón, Pilar, Parra, Josep-Lluís, Marlow, Sara, Scaltriti, Maurizio, Pérez-Garcia, José, Prat, Aleix, Arribas, Joaquín, Hahn, William C., Kim, So Young, Baselga, José
Publicado em 2014

PIK3CA Mutations Are Associated With Decreased Benefit to Neoadjuvant Human Epidermal Growth Factor Receptor 2–Targeted Therapies in Breast Cancer

Por Majewski, Ian J., Nuciforo, Paolo, Mittempergher, Lorenza, Bosma, Astrid J., Eidtmann, Holger, Holmes, Eileen, Sotiriou, Christos, Fumagalli, Debora, Jimenez, Jose, Aura, Claudia, Prudkin, Ludmila, Díaz-Delgado, Maria Carmen, de la Peña, Lorena, Loi, Sherene, Ellis, Catherine, Schultz, Nikolaus, de Azambuja, Evandro, Harbeck, Nadia, Piccart-Gebhart, Martine, Bernards, René, Baselga, José
Publicado no J Clin Oncol (2015)